The FDA Expands the Types of Confirmatory Evidence Sources to Support Drug Effectiveness Studies
Learn how the inclusion of real-world data (RWD) and evidence from natural history studies can improve your integrated evidence strategy.
Understanding the Importance of Utilizing Social Determinants of Health
This white paper explores using the elements of social determinants of health (SDOH) to create optimal patient services program design.
Improve Patient Diversity and Expand Access in a Real-World Setting
Boost enrollment in clinical studies that reflects the diversity of the population who will use the medical product.
Global Evidence Generation Checklist
Help guide internal conversations and begin to assess evidence gaps for your therapeutic with UBC’s Evidence Generation Checklist.
Planning Real-World Studies to Support Cell and Gene Therapy Evidence Generation Needs
As the cell and gene therapy pipeline evolves, manufacturers are now faced with the need to provide long-term safety and efficacy data.
Optimizing the Patient Journey Through High-Tech, High-Touch Services
Learn to balance personal connection and technological efficiencies for improved patient adherence, access, and affordability solutions in this whitepaper.
How to Start Your Real-World Evidence Journey
Figure out how to maximize product value with early, integrated RWE planning.
Optimizing Evidence Generation in Rare Disease Studies with Patient-Centric Strategies
RWD and RWE are emerging as strategic tools in rare disease study design to address research challenges with real-world solutions.
Modern Approaches and Considerations for Designing Real-World Studies
Keep up to date with strategic planning best practices and patient-centric, modern study design.
